Polyp of Colon Clinical Trial
Official title:
A Prospective, Non-randomized Multicenter Study Verifying C-REX LapAid and C-REX DMH/DMHC
In colorectal surgery, hand suturing and stapling are routine methods for performing
intestinal anastomoses, and these methods appear to be similar in terms of clinical safety.
Despite several years of experience with surgical procedures as well as improvements to the
medical devices, problems with disturbed anastomotic healing leading to leakage and stenosis
after colorectal surgery remain a significant challenge for surgeons. In addition,
preoperative radiotherapy has been shown to increase the risk of anastomotic leakage even
further.
The methods that are used today to detect leakages are unfortunately inaccurately and limited
to monitoring symptoms, temperature, CRP (C-reactive protein)-levels, and performing
abdominal examinations and CT-scans. These clinical signs and parameters usually become
apparent several days after onset of the leakage, which leads to a delayed diagnosis.
Anastomotic leakage is not only a significant cause of increased morbidity of complications
and mortality in patients, but also associated with increased risk of local recurrence and
poor prognosis. Moreover, when reoperation is required to fix the leakage, a permanent stoma
may be made at the level of the sigmoid colon and this procedure impacts quality of life
negatively.
Based on the above considerations, a novel, adaptive anastomotic method has been developed by
CarpoNovum to achieve a safer anastomosis. The method's working name is C-REX Ring-locking
Procedure (C-REX is referred to our Colorectal anastomotic rings for Re-join the intestinal
ends and validate the anastomosis, with function of Extract samples for analysis and conduct
X-ray through connected catheters).
The novel adaptive anastomotic medical devices, C-REX LapAid and C-REX DMH/DMHC are easy to
use, with unique possibility to control the anastomosis during and after surgery. The
previous successful preclinical study encourages a clinical verification in patients
undergoing colonic resection to evaluate the safety and performance of C-REX Ring-locking
Procedure by use of C-REX LapAid and C-REX DMH/DMHC.
OVERALL DESIGN The study is a prospective, multicenter, single arm study Possible study
candidates are patients requiring resection of the left colon (descending colon and sigmoid)
or the upper rectum (15cm above the anal rim) due to malign or benign disease. After physical
examination, checking of inclusion/exclusion criteria, and after informed consent has been
achieved, potential subjects will be enrolled in the study, and the investigational surgery
will be performed during hospitalization. The devices, i.e. C-REX LapAid and C-REX DMH/DMHC
(dual male handle/dual male catheter handle), included in C-REX Ring-locking Procedure are
applied to the inside of the intestine and connected to catheters that allow monitoring of
the anastomosis (if DMC is applied).
The healing period is expected to be approximately 10 ± 2 days. The short-term implant, i.e.
the anastomotic ring, detaches via necrosis on the inner part of the intestinal surface and
is expelled the natural way during hospitalization.
The subject can be discharged from the hospital when the short-term implant has been
evacuated, and the subject has begun to eat and has normal bowel movements. The observation
period lasts until 30 days after surgery. The subject then continues follow-up according to
local routine.
QUALITY CONTROL Authorization to perform C-REX Ring-locking Procedure According to
CarpoNovum's regulation (Document 0041: Procedure, Accreditation of Surgeons for Clinical
Studies), clinical investigators must be authorized to conduct the C-REX Ring-locking
Procedure with C-REX LapAid and C-REX DMH/DMHC by performing at least one surgery on pigs and
at least one train-in surgery on patients with the person in charge of the study (Dr. Anders
Grönberg). When the clinical investigator is authorized to perform the C-REX Ring-locking
Procedure with C-REX LapAid System, he or she receives a certificate. This certificate could
also admit the clinical investigator the right to authorize other surgeons to perform C-REX
Ring-locking Procedure with C-REX LapAid and C-REX DMH/DMHC (i.e. to perform at least one
operations on pigs and at least one train-in operations on patients with the authorized
clinical investigator).
Monitoring To ensure that the study is appropriately conducted, a monitor appointed by the
sponsor will visit the investigation site regularly and oversee the investigator's compliance
with the CIP, perform source-data verification and report to the sponsor on the progress of
the study.
Each investigation site and clinical investigator in the study will be monitored. On all
occasions, the responsible monitor and/or the person in charge of the study will secure for
example that:
1. Compliance with CIP (clinical investigation plan) is maintained and any deviation from
CIP is discussed with the clinical investigators, documented and reported to the
sponsor; if the changes are significant, the competent authority and the ethical
committee will be informed;
2. The device is being used according to CIP, IB (investigator's brochure) and IFU
(instructions for use), and if modifications are required either to the device or its
method of use or to the CIP, this need shall be reported to the sponsor;
3. Signed and dated informed consent forms have been obtained from each subject at the time
of enrollment and before any study-related procedures are undertaken;
4. The data in CRFs (case report forms) are complete, are recorded in a timely manner and
are consistent with the source data;
5. Traceability and device accountability of the investigational device are properly
maintained;
6. Maintenance and calibration of equipment relevant for assessment of the study is
performed;
7. Possible adverse events or device deficiencies have been properly documented and
reported;
8. Subjects withdrawal and/or non-compliance is documented and discussed with the clinical
investigator and reported to the sponsor;
9. Clinical investigators have and continue to have staff and facilities to conduct the
study safely and effectively;
10. Clinical investigators have and continue to have access to an adequate number of
subjects and the investigational device to complete the study.
The responsible monitor will write a report after each visit to the medical institutions. The
reports will be sent to the sponsor and the principal clinical investigators.
Documentation and data processing Medical record of subjects
The following information should be clearly documented in medical record of subjects:
- That the subject is informed about the study and that the subject has signed the
informed consent forms.
- That the subject is participating in the study; the identification code for the subject,
the name of the study, and the study number (i.e., CREX-003).
- Which treatment the study refers to (i.e., C-REX Ring-locking Procedure with use of
C-REX LapAid and C-REX DMH/DMHC).
- Name of the principal clinical investigator.
- All AEs (adverse events) and device deficiencies.
Document and data control Prior to commencement of the study, clinical investigators and
their staff will be informed about CIP, CRFs and other study documents and procedures.
For each subject enrolled, regardless of medical device initiation, a CRF must be completed
and signed by corresponding investigation personnel. This applies to those subjects who fail
to complete the study. If a subject withdraws from the study, the reason must be noted on
CRF.
Data and information of subjects derived from the study are considered as source data. To
ensure that all data are complete and correct, source data verification (SDV) will be
confirmed by the monitor.
Comments in CRF should be made with a ballpoint pen with permanent ink. If comments are
missing in CRF, reasons for this must be stated. No questions, squares, fields or similar
should be left without comments.
CRF entries and corrections will only be performed by investigational personnel, authorized
by the principle clinical investigator. Errors should be crossed out but not obliterated, the
correction inserted, and the change initialed and dated by the clinical investigator.
Then entries will be checked by the monitor and any errors or inconsistencies will be checked
and corrected immediately.
The responsible clinical investigator is obliged to keep the subject identification lists
with the subject's identification code and identity in a safe place at the investigation site
(hospital), accessible only to the investigation personnel. These source data and subject
identification lists will be saved for 10 years after the close of the study at the medical
institution.
NUMBER OF SUBJECTS The aim of this study is to verify the novel device in clinical practise
and for CE (Conformité Européenne) marking later. Since no control group is included, there
is no need for power determinations.
Considering that similar anastomotic devices have been used in clinic for decades, 20
subjects will be included in The First Affiliated Hospital of Xiamen University.
STATISTICAL ANALYSIS OF VARIABLES Descriptive methods are used to analyze the data collected
in the study. The incidences of anastomotic leakage and other AEs/device deficiencies are
calculated.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05178095 -
Artificial Intelligence in Colonic Polyp Detection
|
N/A | |
Completed |
NCT04551014 -
Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm
|
N/A | |
Completed |
NCT04551001 -
Evaluation of Cold Forcep and Cold Snare Polypectomy for Polyps Less Than or Equal to 3mm in Size During Colonoscopy
|
N/A | |
Completed |
NCT04378660 -
Artificial Intelligence (AI) Validation Study for Polyp Detection
|
N/A | |
Completed |
NCT04442607 -
Clinical vAliDation of ARTificial Intelligence in POlyp Detection
|
N/A | |
Completed |
NCT05499546 -
Virtual Scale Function SCALE EYE: Variability and Systematic Differences
|
N/A | |
Completed |
NCT04195646 -
Computer Aided Detection of Polyps During Colonoscopy Procedures
|
N/A | |
Completed |
NCT04899700 -
Linked Color Imaging Versus White Light Endoscopy for the Evaluation of Scars of Non-pedunculated Polyps. LCI Scar Study.
|
N/A | |
Recruiting |
NCT04500392 -
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity
|
N/A | |
Recruiting |
NCT06447012 -
Artificial Intelligence Development for Colorectal Polyp Diagnosis
|
||
Completed |
NCT04357158 -
Breath Analysis as an Additional Test for Colorectal Cancer Screening to Reduce the Number of Unnecessary Colonoscopies
|
N/A | |
Completed |
NCT05389397 -
De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas
|
N/A | |
Completed |
NCT04032912 -
The Non-Optical Resect and Discard Study (NORD)
|
||
Recruiting |
NCT05730192 -
EAGLE Trial CADDIE Artificial Intelligence Endoscopy
|
N/A | |
Completed |
NCT05829447 -
Combining Artificial Intelligence With Balloon Mucosal Exposure Device for Polyp Detection in Screening Individuals
|
N/A | |
Completed |
NCT04647266 -
Pronostic Score of Morbidity to Determine Risk of Complications After Endoscopic Submucosal Dissection for Colorectal Lesions
|
||
Not yet recruiting |
NCT06271941 -
Prophylactic Double Thermal Ablation After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps
|
N/A | |
Recruiting |
NCT04117100 -
Advanced Endo-therapeutic Procedure : Registry-based Observational Study
|
||
Active, not recruiting |
NCT03089268 -
Molecular and Histological Characteristics of Serrated Lesions of the Colon
|
||
Completed |
NCT04924543 -
OPtical Diagnosis Training to Improve Dysplasia Characterisation in IBD
|
N/A |